While artificial intelligence (AI) holds promise to improve the diagnosis of melanoma, researchers of a new review outlined ...

Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the ...

Rachel Rohaidy, MD, of Miami Neuroscience Institute and Baptist Health, discusses how the evolving treatment landscape is ...

Artificial intelligence (AI)–based electrocardiogram interpretation (AI-ECG) detected left ventricular systolic dysfunction ...

Financial, family, and logistical challenges often lead patients to choose ongoing therapies over stem cell transplantation, ...

FDA issues a complete response letter for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients with chronic ...

In myasthenia gravis, complement plays a big role in what happens to the muscle end of the neuromuscular junction, explains ...

Researchers called for standardized health outcome descriptors to help bridge communication gaps in rheumatology care and ...

A panelist discusses how the highest unmet needs in acute myeloid leukemia include treatments for patients with refractory ...

Caregivers and patients with acute leukemia face unique challenges, prioritizing treatment preferences that impact quality of ...

Jody Agena, PharmD, MBA, director of pharmacy operations, Virginia Cancer Specialists, discusses the various responsibilities of the pharmacist within community oncology settings.

The recent increase in prolonged emergency department (ED) stays and boarding times for older adults reveals systemic challenges in US hospital care.